Colorado StemWave

The Research, backed by Clinical Evidence.

Study 1: Long term randomized controlled trial in chronic plantar fasciitis

149 patients tracked for up to 6 years. The shockwave group reported 69.1 percent excellent and 13.6 percent good outcomes, with a recurrence rate of just 11 percent versus 55 percent in the control group.

Citation: Wang et al., The American Journal of Sports Medicine, 2006

Displayed stat callout: 82.7% Excellent or good

Study 2: Individualized protocols for plantar fasciopathy

Study 1: Long term randomized controlled trial in chronic plantar fasciitis

Patients with chronic heel pain saw average pain scores drop from 6.9 to 0.9 out of 10 over one year, with a 98 percent success rate at the one year follow up and only 8 percent recurrence.

Citation: Retrospective clinical study, PMC, 2016

Displayed stat callout: 98% 1 year success

Study 3: Calcific shoulder tendinopathy outcomes

Study 1: Long term randomized controlled trial in chronic plantar fasciitis

Study 4: How it works — restarting the healing cascade

Individualized shockwave treatment reduced average pain from 6.7 to 0.8 out of 10 at one year, with a 92 percent success rate and 7 percent recurrence.

Citation: Retrospective clinical study, PMC, 2017

Displayed stat callout: 92% 1 year succes

Study 4: How it works — restarting the healing cascade

Study 1: Long term randomized controlled trial in chronic plantar fasciitis

Study 4: How it works — restarting the healing cascade

Researchers describe the mechanism directly: shockwave therapy stimulates the wound healing cascade, turning chronic damage into acute damage and initiating the body's normal repair process.

Citation: Scientific Reports, PMC, 2019

Displayed stat callout: The Mechanism